November 10, 2022

### A Turning Point for Immuno-Oncology

Immunotherapy has been the holy grail in the fight against cancer for the last decade. For good reason, we’ve been...

by Tim Reilly

[Read more](/content/a-turning-point-for-immuno-oncology/index.html)

July 13, 2021

### Immuno-Oncology: The Comeback Kid

Now 10 years into the golden era of immuno-oncology (I-O) following the first FDA approval of ipilimumab (anti-CTLA4) in 2011…

by Tim Reilly

[Read more](/content/immuno-oncology-the-comeback-kid/index.html)